Novavax (NVAX) Metrics: History & Chart

Novavax, Inc.(NVAX)

Biotechnology · Gaithersburg, MD

$11.25-1.31 (-10.43%)

Delayed quote: Oct 6, 2026, 12:00 PM EDT

About Novavax, Inc.

Novavax, Inc. is a biotechnology firm dedicated to discovering, developing, and commercializing vaccines aimed at preventing serious infectious diseases and addressing critical health needs. The company's diverse pipeline includes NVX-CoV2373, a coronavirus vaccine candidate currently undergoing two Phase III trials, one Phase IIb, and one Phase I/II trial. Also featured is NanoFlu, a nanoparticle-based seasonal quadrivalent influenza vaccine in Phase 3 clinical trials. Furthermore, Novavax is advancing ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine, which is in Phase II clinical trials for adults aged 60 and older, and in Phase I for pediatric use. The company holds a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of its COVID-19 vaccine candidate, NVX-CoV2373. Established in 1987, Novavax, Inc. is headquartered in Gaithersburg, Maryland.

Gaithersburg, MD

749 employees

www.novavax.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: John Charles Jacobs

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	+16.30%
30D Total Return	+22.90%
YTD Total Return	+86.90%
1Y Total Return	+32.77%
3Y Total Return	+76.17%
5Y Total Return	-92.61%
10Y Total Return	-68.74%
15Y Total Return	-58.41%
20Y Total Return	-84.09%

2026	+86.90%
2025	-16.42%
2024	+67.50%
2023	-53.31%
2022	-92.81%
2021	+28.30%
2020

CAGR TTM	+32.59%
CAGR 3Y	+20.77%
CAGR 5Y	-40.61%
CAGR 10Y	-10.98%
CAGR 15Y	-5.68%
CAGR 20Y	-8.78%

PE Ratio	3.92
PE Ratio Avg TTM	3.58
PE Ratio Avg 3Y	3.58
Current VS TTM Avg	+9.45%
Current VS 3Y Avg	+9.45%
Current VS 5Y Avg	+9.45%

All Metrics

NVAX Valuation Metrics

NVAX Stock Price Metrics

NVAX Dividend Metrics

NVAX Growth Rate Metrics

NVAX Discounted Cash Flow Metrics

NVAX Returns By Period

NVAX Yearly Returns

NVAX Average Annual Returns By Period (CAGR)

NVAX Revenue Metrics

NVAX PE Ratio Metrics

NVAX PS Ratio Metrics

NVAX PB Ratio Metrics

NVAX Price to Free Cash Flow Ratio Metrics

NVAX Debt to Equity Ratio Metrics

NVAX PEG Ratio Metrics

NVAX FCF Yield

NVAX Earnings Yield

NVAX EBITDA Yield

NVAX OCF Yield

NVAX EV/EBIT Ratio Metrics

NVAX EV/EBITDA Ratio Metrics

NVAX EV/Assets Ratio Metrics

NVAX EV/Sales Ratio Metrics

NVAX Current Ratio Metrics

NVAX Quick Ratio Metrics

NVAX ROIC Metrics

NVAX Return on Assets Metrics

NVAX Return on Equity Metrics

NVAX Net Profit Margin Metrics

NVAX Gross Profit Margin Metrics

NVAX Tax Rate Metrics

PS Ratio	5.00
PS Ratio Avg TTM	1.97
PS Ratio Avg 3Y	1.55
Current VS TTM Avg	+153.24%
Current VS 3Y Avg	+222.59%
Current VS 5Y Avg	+204.76%

PB Ratio	35.75
PB Ratio Avg TTM	39.65
PB Ratio Avg 3Y	39.65
Current VS TTM Avg	-9.84%
Current VS 3Y Avg	-9.84%
Current VS 5Y Avg	+22.59%

PFCF Ratio	14.76
PFCF Ratio Avg TTM	22.72
PFCF Ratio Avg 3Y	81.22
Current VS TTM Avg	-35.03%
Current VS 3Y Avg	-81.83%
Current VS 5Y Avg	-81.83%

Debt/Equity Ratio	(1.55)
Debt/Equity Ratio Avg TTM	(0.21)
Debt/Equity Ratio Avg 3Y	(1.06)
Current VS TTM Avg	-627.04%
Current VS 3Y Avg	-46.58%
Current VS 5Y Avg	-125.12%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	6.77%
FCF Yield Avg TTM	4.74%
FCF Yield Avg 3Y	3.25%
Current VS TTM Avg	+42.74%
Current VS 3Y Avg	+108.03%
Current VS 5Y Avg	+108.03%

Earnings Yield	25.53%
Earnings Yield Avg TTM	27.68%
Earnings Yield Avg 3Y	27.68%
Current VS TTM Avg	-7.76%
Current VS 3Y Avg	-7.76%
Current VS 5Y Avg	-7.76%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	3.51
Ev/Ebit Ratio Avg TTM	3.62
Ev/Ebit Ratio Avg 3Y	3.62
Current VS TTM Avg	-3.09%
Current VS 3Y Avg	-3.09%
Current VS 5Y Avg	-3.09%

Ev/Ebitda Ratio	3.31
Ev/Ebitda Ratio Avg TTM	3.28
Ev/Ebitda Ratio Avg 3Y	3.28
Current VS TTM Avg	+0.77%
Current VS 3Y Avg	+0.77%
Current VS 5Y Avg	+0.77%

Ev/Assets Ratio	2.27
Ev/Assets Ratio Avg TTM	1.32
Ev/Assets Ratio Avg 3Y	0.89
Current VS TTM Avg	+71.49%
Current VS 3Y Avg	+155.33%
Current VS 5Y Avg	+170.91%

Ev/Sales Ratio	5.25
Ev/Sales Ratio Avg TTM	2.04
Ev/Sales Ratio Avg 3Y	1.28
Current VS TTM Avg	+157.71%
Current VS 3Y Avg	+311.35%
Current VS 5Y Avg	+249.12%

Current Ratio	2.33
Current Ratio Avg TTM	2.31
Current Ratio Avg 3Y	1.51
Current VS TTM Avg	+0.77%
Current VS 3Y Avg	+54.89%
Current VS 5Y Avg	+78.60%

Quick Ratio	2.30
Quick Ratio Avg TTM	2.29
Quick Ratio Avg 3Y	1.48
Current VS TTM Avg	+0.74%
Current VS 3Y Avg	+55.27%
Current VS 5Y Avg	+79.91%

ROIC	(36.37%)
ROIC Avg 3Y	(8.80%)
ROIC Avg 5Y	(84.38%)
Current VS 3Y Avg	-313.45%
Current VS 5Y Avg	+56.89%
Current VS 10Y Avg	+44.08%

ROA	(25.92%)
ROA Avg TTM	(2.84%)
ROA Avg 3Y	(3.57%)
Current VS TTM Avg	-813.29%
Current VS 3Y Avg	-626.52%
Current VS 5Y Avg	-250.56%

ROE	N/A
ROE Avg TTM	(148.47%)
ROE Avg 3Y	(132.15%)
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Net Profit Margin	(59.87%)
Net Profit Margin Avg TTM	(66.36%)
Net Profit Margin Avg 3Y	(54.58%)
Current VS TTM Avg	+9.79%
Current VS 3Y Avg	-9.69%
Current VS 5Y Avg	+2.29%

Gross Profit Margin	93.67%
Gross Pft Margin Avg TTM	79.86%
Gross Pft Margin Avg 3Y	71.38%
Current VS TTM Avg	+17.30%
Current VS 3Y Avg	+31.23%
Current VS 5Y Avg	+26.61%

Tax Rate	2.10%
Tax Rate Avg 3Y	0.86%
Tax Rate Avg 5Y	0.93%
Current VS 3Y Avg	+143.98%
Current VS 5Y Avg	+125.19%
Current VS 10Y Avg	+125.19%